Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.

Thrombosis and haemostasis - 1 Feb 2009

Licht Christoph, Fremeaux-Bacchi Veronique

Abstract excerpt

Membranoproliferative glomerulonephritis (MPGN) is a chronic progressive renal disease that is diagnosed on the basis of renal histological features. Several MPGN subtypes have been defined by the localization and composition of glomerular deposits (electron dense, Ig and C3). MPGN II or dense deposit disease (DDD) which is defined by the occurrence of electron dense deposits within the lamina densa of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Complement Activation
Share to Complement C3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement Factor H

Share to Complement Factor I

Share to Glomerulonephritis, Membranoproliferative

Share to Membrane Cofactor Protein

Share to Terminology as Topic

Source

Identifiers

PMID: 19190809

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.PMID 19190809Read ↗

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.Semantic proximity Read ↗

Genetic and acquired abnormalities in C3 glomerulopathy and primary immune complex-mediated MPGNSemantic proximity Read ↗

C3 Glomerulopathy: A Review with Emphasis on Ultrastructural FeaturesSemantic proximity Read ↗

Acquired and genetic determinants of disease phenotype and therapeutic strategies in C3 glomerulopathy and immunoglobulin-associated MPGNSemantic proximity Read ↗

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.Semantic proximity Read ↗

Recent insights into C3 glomerulopathySemantic proximity Read ↗

Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNSemantic proximity Read ↗

C3 glomerulopathy: what's in a name?Semantic proximity Read ↗

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.Semantic proximity Read ↗

Genetic analysis of the complement pathway in C3 glomerulopathy.Semantic proximity Read ↗

Dense Deposit Disease and C3 GlomerulopathySemantic proximity Read ↗

Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.